JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
VEVYX
Price
$52.21
Change
-$0.41 (-0.78%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs VEVYX

Header iconJVMTX vs VEVYX Comparison
Open Charts JVMTX vs VEVYXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
Victory Sycamore Established Value Y
Price$52.21
Change-$0.41 (-0.78%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs VEVYX Comparison Chart
Loading...
VS
JVMTX vs. VEVYX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and VEVYX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. VEVYX (19.5B). VEVYX pays higher dividends than JVMTX: VEVYX (1.26) vs JVMTX (0.73). JVMTX was incepted earlier than VEVYX: JVMTX (11 years) vs VEVYX (12 years). JVMTX is a more actively managed with annual turnover of: 41.00 vs. VEVYX (28.00). JVMTX has a lower initial minimum investment than VEVYX: JVMTX (0) vs VEVYX (1000000). VEVYX (19.73) and JVMTX (19.27) have marching annual gain over last year. JVMTX return over 5 years is better than : 43.64 vs. VEVYX (40.78).
JVMTXVEVYXJVMTX / VEVYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years12 years-
Gain YTD11.01014.13578%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B19.5B120%
Annual Yield % from dividends0.731.2658%
Returns for 1 year19.2719.7398%
Returns for 3 years13.3812.66106%
Returns for 5 years43.6440.78107%
Returns for 10 years63.3463.9899%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems